Asilomar Conference on Mass Spectrometry
Metabolite Profiling: Biomarker Discovery, Drug Efficacy and Fundamental Biochemistry
October 15 – 19, 2004
“Metabolites have gained increasing interest over the past five years largely
for their implications in diagnostic and pharmaceutical biomarker discovery.
Although numerous small molecules are routinely measured in biofluids as indicators
of health little is known about the vast majority of metabolites. For example,
biofluids contain thousands of components many of which remain structurally and
functionally uncharacterized. For this reason metabolite research and its potential
in health and pharmaceutical development has become one of the most exciting
areas of biological discovery. Three of the broad aims of this field are to identify
new disease biomarkers, monitor physiological reactions to administered drugs
and to understand the function of metabolites. This Asilomar meeting will focus
on the latest challenges in metabolite profiling spanning a broad range of interests
including research trends and instrument developments.”
If you are interested in participating as a speaker, please contact Gary Siuzdak.